Main Menu

Dr Marco Gerlinger

Team Leader

The alt text
Dr Marco Gerlinger develops new tools to detect and track the evolution of cancer cells within tumours and better therapies which prevent the evolution of drug resistance. He is a team leader in the ICR's Centre for Cancer and Evolution, and holds a Honorary Consultant Medical Oncologist position at the Royal Marsden Hospital, where he treats patients with gastrointestinal cancers. Team: Translational Oncogenomics

T 020 71535 234


Dr Marco Gerlinger studied Medicine in Munich, Wurzburg, London and Boston. After obtaining his MD from the Institute for Immunology in Munich, he undertook postdoctoral training in cancer immunotherapy at the University of Zurich. He specialized in Internal Medicine and Medical Oncology in Zurich and London. As a postdoc and subsequently as a clinician scientist at the CRUK London Research Institute, he investigated biomarkers of targeted cancer drug resistance and developed technologies to measure and track genetic and functional intra tumour heterogeneity and cancer evolution.

Dr Gerlinger joined the ICR Centre for Evolution and Cancer as a new team leader in October 2013. He is also a Consultant Medical Oncologist at the Royal Marsden Hospital where he is treating patients with gastrointestinal cancers. 

We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.